Health on the Hill: Three Threads Driving Congress This Week
The big picture: A packed week of health policy legislation activity on Capitol Hill reveals three dominant storylines — a bipartisan push to rein in prescription drug costs through the supply chain, mounting alarm over healthcare access in rural America, and an escalating partisan fight over federal public health funding cuts and the fallout from expiring ACA subsidies.
Key takeaways:
- Prescription drug supply chain reform got its most prominent airing yet in the House Energy and Commerce Committee, with lawmakers examining the role of pharmacy benefit managers in driving up costs — a rare area of bipartisan energy.
- Rural healthcare access is emerging as the quiet consensus issue of the 119th Congress, with members from both parties highlighting workforce shortages, hospital funding, and community health center investments.
- Federal health funding cuts and ACA subsidy expiration are fueling a sharp partisan divide, with Democrats warning of a coverage crisis and Republicans defending fiscal discipline — all while the measles outbreak adds urgency.
Prescription Drug Costs and the Supply Chain Fight
The problem
Americans pay more for prescription drugs than patients in any other wealthy nation, and Congress is zeroing in on one set of middlemen it believes is partly responsible: pharmacy benefit managers. PBMs negotiate drug prices between manufacturers, insurers, and pharmacies — but critics in both parties say their opaque business practices inflate costs rather than reduce them.
The House Energy and Commerce Committee's Health Subcommittee held a hearing on February 11 titled "Lowering Health Care Costs for All Americans: an Examination of the Prescription Drug Supply Chain", the latest in a series of sessions this Congress examining healthcare costs. This follows a January 22 hearing on health insurance affordability and a full committee hearing with health insurance CEOs the same day.
Key players and points of contention
The hearing exposed a familiar fault line. Rep. Frank Pallone Jr. (D-NJ), the ranking Democrat on Energy and Commerce, accused Republicans of lacking a genuine plan: "Republicans are holding this hearing because they have no real plan to lower health costs or improve quality of care... This was a $9 billion Republican handout to the pharmaceutical industry, tucked away in the Big Ugly Bill."
On the other side of the aisle, Sen. Bill Cassidy (R-LA) touted a legislative win: "President Trump SIGNED my bill that ensures drug discounts work to DECREASE Americans' health care costs, NOT increase profit for shareholders. Big win for patients!!"
The bipartisan FY2026 spending deal that recently passed the House included PBM reform provisions — new limits on PBM compensation models in Medicare, transparency requirements, and stronger oversight of PBM contracting with pharmacies — as reported by Politico. That deal represents the most significant Medicare Medicaid legislation targeting drug intermediaries in years.
Who's lobbying
The Pharmaceutical Research and Manufacturers of America (PhRMA) spent $10.7 million in Q4 2025 alone on lobbying — making it the fourth-largest lobbying spender on health issues. The American Hospital Association ($7.0 million) and American Medical Association ($5.7 million) also spent heavily. AARP, which has pushed for drug pricing reform on behalf of seniors, reported $5.7 million in Q4 lobbying expenditures on federal health programs and related issues.
The U.S. Chamber of Commerce, the single largest health-issue lobbying spender at $18.3 million in Q4 2025, has also weighed in on supply chain regulation, though its healthcare lobbying Congress portfolio spans far beyond drug pricing.
What comes next
The Energy and Commerce Committee's sustained focus on drug pricing — three major hearings in January alone, plus this week's session — signals that additional health policy legislation targeting PBMs and the broader supply chain could move through committee this session. Whether the bipartisan energy holds as the debate shifts from hearings to markup remains the central question.
Rural Healthcare Access: A Quiet Bipartisan Consensus
The problem
Rural hospitals are closing. Provider shortages are worsening. And members of Congress from farm states and small towns — regardless of party — spent this week sounding the alarm.
The Senate Special Committee on Aging held a hearing on February 11 titled "Hearings to Examine How Washington's Rules Drove Physicians out of Medicine", directly addressing the regulatory burden that members say is accelerating physician burnout and driving doctors away from practice, particularly in underserved areas.
Key players
The volume of member statements on rural health this week was striking for its bipartisan character.
Sen. Steve Daines (R-MT) highlighted his recognition from the National Association of Community Health Centers: "Honored to receive the Distinguished Community Health Center Advocate Award from the National Association of Community Health Centers. I'll always fight for our small town and rural healthcare providers."
Sen. Chuck Grassley (R-IA) reported meeting with the Iowa Rural Health Association to discuss "Medicare & Medicaid Workforce Rural Health Transformation Fund Rural health clinics."
Rep. Mariannette Miller-Meeks (R-IA-1) described her focus on "workforce challenges, the Rural Health Care Transformation Program, and how technology can complement providers, improve efficiency, and expand access to care for rural communities."
On the Democratic side, Rep. Don Davis (D-NC-1) offered a blunt assessment: "Rural health systems and the communities they serve have been left behind for far too long. Federal, state, and local partners must come together to support entities like @ECUHealthNC."
Sen. Shelley Moore Capito (R-WV) pointed to a concrete investment: "With @potus signing the recent appropriations package into law, Concord University will now be receiving funding to establish a Center for Rural Healthcare Workforce Solutions."
Rep. Ryan Zinke (R-MT) cited specific dollar figures: "The One Big Beautiful Bill delivers $233 million directly to Montana's rural hospitals."
Sen. Katie Britt (R-AL) said she met with CMS leadership "to discuss advancing @POTUS's agenda to strengthen rural health care."
Healthcare policy overview: What's moving
Multiple legislative vehicles are in play. The FY2026 spending deal boosted community health center funding to $4.6 billion, according to JD Supra. Telehealth extensions through 2027, included in that same package, are particularly significant for rural areas where provider access is limited. Rep. Chris Pappas (D-NH-1) is pushing to make Medicare telehealth coverage permanent: "Telehealth enables Granite Staters to virtually access the right care at the right time while saving them both time and money."
Rep. Derrick Van Orden (R-WI-3) announced he had "secured $3M to help expand access to health care in Wisconsin's communities."
The bipartisan nature of these statements suggests rural health provisions could be among the least contentious elements of any broader healthcare policy overview this session — a rarity in today's Congress.
Federal Health Funding Cuts and ACA Subsidy Expiration: A Partisan Collision
The problem
Two converging crises are driving the sharpest partisan divide in health policy this week. The enhanced Affordable Care Act premium tax credits expired at the end of 2025, and the Trump administration has moved to cut hundreds of millions in public health funding to states — developments Democrats say amount to a healthcare access emergency.
Meanwhile, the One Big Beautiful Bill Act's Medicaid provisions are now being implemented. The CBO has estimated that approximately 11.8 million people could lose Medicaid coverage under the law's changes, which include six-month eligibility redeterminations and restrictions on provider taxes states use to fund their Medicaid match, according to an analysis by the Urban Institute.
The partisan divide
Democrats spent the week hammering the administration.
Rep. Mike Levin (D-CA-49) was among the most forceful: "His Administration just cut $600 MILLION in public health funding from four Democratic states, including $400 MILLION ripped straight from California's state and local public health departments... And they're doing it in the middle of a MEASLES OUTBREAK."
Sen. John Hickenlooper (D-CO) echoed the concern: "By cancelling this funding, President Trump is jeopardizing the health of Coloradans and making America more susceptible to future outbreaks. These cuts should be reversed immediately."
Sen. Michael Bennet (D-CO) added: "President Trump's reported CDC cuts will gut programs that prevent disease and address health disparities across Colorado's rural towns and most vulnerable communities."
On Affordable Care Act updates, Sen. Jeanne Shaheen (D-NH) described the premium impact directly: "With the expiration of the ACA enhanced premium tax credits, Americans are seeing their premiums skyrocket—some by thousands of dollars. Health care costs are eating into the incomes of everyday Americans."
Sen. Elizabeth Warren (D-MA) framed it as a moral issue: "You should never have to choose between paying for health insurance or keeping a roof over your head. Never."
Rep. Stephen Lynch (D-MA-8) connected the threads: "I will continue to fight against the Trump Administration's cuts to Medicaid, ACA Tax Credits, and other federal funding that our Community Health Centers rely on."
Rep. Yvette Clarke (D-NY-9) raised reproductive health access: "Planned Parenthood health centers save lives. But this administration's efforts to defund their programs are only putting women in harm's way—limiting access to cancer screenings, STI testing, and essential, equitable care."
Where things stand legislatively
The House passed a three-year clean extension of ACA subsidies in January, with 17 Republicans crossing the aisle, Politico reported. But Senate bipartisan talks on a compromise have been described as on "shaky ground", and the subsidies were notably excluded from the FY2026 spending deal.
The CBO scored the House GOP's standalone health package at $35.6 billion in savings but estimated it would leave 100,000 fewer people per year with health insurance through 2035.
Healthcare lobbying Congress activity
The stakes are reflected in lobbying expenditures. AARP, which has advocated for maintaining coverage protections, spent $5.7 million in Q4 2025. The American Hospital Association — whose member institutions face significant financial exposure from coverage losses — spent $7.0 million. The Business Roundtable, representing major employers with a direct interest in the insurance market, spent $10.9 million.
What to watch
The Senate's next move on ACA subsidies is the single most consequential pending decision in this healthcare policy overview. Without action, millions of marketplace enrollees face a second year of sharply higher premiums. The administration's public health funding cuts, meanwhile, are being implemented without congressional authorization — setting up potential oversight confrontations in the weeks ahead.
Spot something wrong? Report an issue with this article